O04 Mission EB -mesenchymal intravenous stromal cell infusions in children with recessive dystrophic epidermolysis bullosa: a randomised, double-blinded, placebo controlled, crossover trial
Maria L Bageta(Great Ormond Street Hospital for Children NHS Foundation Trust), Anna E. Martinez(National Health Service), I. H. Wilson(University of Sheffield), Cindy Cooper(Department of Health and Social Care), Marie‐Louise Lovgren(Birmingham Women's Hospital), Muhammad Nadeem(University of Sargodha), Pratima Poudel(Birmingham Women's Hospital), Matthew Bursnall(University of Sheffield), Katie Biggs(University of Sheffield), Malobi Ogboli(Birmingham Women's Hospital), Gabriela Petrof(Great Ormond Street Hospital), Diana Papaioannou(University of Sheffield), Shamila Ditta(University of Sheffield), Rachel Glover(University of Sheffield), Pablo López Balboa(Great Ormond Street Hospital), John hn Mcgrath(King's College London), Katie Hutchence(University of Sheffield), Steven A. Julious(University of Sheffield)
Cited by 0
Related Papers
Estimating the sample size for a pilot randomised trial to minimise the overall trial sample size for the external pilot and main trial for a continuous outcome variable
|Statistical Methods in Medical Research|2015|2k
What is a pilot or feasibility study? A review of current practice and editorial policy
|BMC Medical Research Methodology|2010|1.6k
Inherited epidermolysis bullosa: Updated recommendations on diagnosis and classification
|Journal of the American Academy of Dermatology|2014|933
Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility
|British Journal of Dermatology|2020|778
Transition of care for adolescents from paediatric services to adult health services
|Cochrane Database of Systematic Reviews|2016|534